Transgene's viral cancer vaccine flunks midphase test—but subgroup signal spurs ongoing analysis

Transgene's viral cancer vaccine flunks midphase test—but subgroup signal spurs ongoing analysis ntaylor Mon, 10/14/2024 - 05:01